Trending

BHEL's order book is booming. Should you care?

Rs 1.95 lakh crore in orders sounds great, but execution and earnings still lag

Rs 1.95 lakh crore in orders sounds great, but execution and earnings still lagAI-generated image

BHEL's order book is making headlines. The number is huge—Rs 1.95 lakh crore. That's nearly double its annual revenue, and the largest the company has ever reported.

But here's the question investors should ask: does a fat order book automatically mean a strong stock? For Bharat Heavy Electricals Limited (BHEL), the answer is a cautious "maybe." Because while the numbers have improved, the core concerns haven't vanished.

What's driving the optimism?

In FY25, BHEL saw revenues rise 19 per cent to Rs 27,350 crore. That's its highest in years. The real buzz, though, is from new orders—over Rs 92,000 crore worth in just one year. A bulk of that came from the power sector, especially thermal projects, thanks to India's renewed focus on energy security.

To its credit, BHEL also commissioned 8.1 GW of thermal capacity in FY25—a big improvement in execution, at least on the surface.

So, from a headline perspective, the company seems to be turning around. That's why the stock—even after falling 11 per cent this year—is still up over 200 per cent in the last two years.

But here's what investors shouldn't ignore

Despite the order wins, BHEL's profitability remains razor thin. Operating margins are still in the low single digits. Returns on capital? Barely above water.

This isn't a company that's printing profits—it's still in rebuild mode. And PSU rebuilds tend to be long, messy and vulnerable to policy changes.

Then there's the valuation problem. BHEL currently trades at a trailing P/E of over 150. That's not just expensive—it's sky-high, especially for a PSU that hasn't shown consistent bottom-line growth.

Execution is everything

If you've followed BHEL over the past decade, you know that order book bloat isn't new. The company has often bagged mega orders only to struggle with timely execution.

That's the risk again. A big pipeline looks great on paper, but delays, cost overruns, or customer-side holdups can quickly derail revenue conversion. And given most of its clients are public sector entities or state discoms, that's always a real risk.

Value Research Online Ratings

Value Research Stock Rating gives BHEL an overall rating of 1 star. The company's specific scores are as follows:

  • Quality Score: 1/10
  • Growth Score: 5/10
  • Valuation Score: 1/10
  • Momentum Score: 4/10

So, should you take a bet on BHEL?

BHEL has a once-in-a-decade opportunity to prove it's more than just a government contractor. The order book gives it a head start. But until it shows consistent execution and healthy profits, investors would be wise to stay realistic—and maybe a little sceptical. And at these valuations, any stumble in execution or slowdown in order inflows could trigger a sharp pullback.

Moreover, our CEO, Dhirendra Kumar, has often pointed out that PSUs aren't designed to create shareholder value. They answer to the government first, and investors later. Their performance is often cyclical, driven more by policy tailwinds than by innovation, efficiency, or sharp execution.

- Use our Stock Screener to compare BHEL's valuation with other capital goods companies.
- Download BHEL's Stock Card for a quick snapshot of financials and peer data

Looking for more than just market buzz?
At Value Research Stock Advisor, we go beyond trends. As a subscriber, you get access to a carefully curated list of high-conviction stock recommendations, three ready-to-use portfolios (aggressive growth, long-term growth and dividend growth) and timely updates—built on long-term thinking, not just headlines. Whether you are looking to build a solid portfolio or simply make more informed investment decisions, we are here to help you cut through the noise.

Disclaimer: This is not a stock recommendation. Do your due diligence before investing. This article was composed with the assistance of artificial intelligence. While we've taught our digital scribe to behave, we still recommend a pinch of healthy scepticism alongside your reading. Enjoy-and proceed with a knowing smile!

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

Other Categories